Maybe it is the lesser focus on papers. If the other things are taken into account and are responsible for a good share of your evaluation, the paper problem is not so pressing. In biology, only high impact factor papers get you jobs and money, thus creating a lot tension in the publishing field. And of course, somthing like that quickly gets monetized...